Interferon-α: Mechanisms of action in chronic myelogenous leukemia in chronic phase

Hematology and Cell Therapy

Volumn 40, Issue 5, 1998, Pages 237-239

  Guilhot, F ^a   Lacotte Thierry, L ^a  

^a University of Poitiers   (France)

Author keywords

Chronic myelogenous leukemia; Interferon

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GROWTH FACTOR;

CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG MECHANISM; GENE CONTROL; HUMAN; IMMUNOSTIMULATION;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; HUMANS; INTERFERON-ALPHA; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; PROTO-ONCOGENE PROTEINS C-FOS; TUMOR CELLS, CULTURED;

EID: 0031796063     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Yanagisawa K, Yamauchi H, Kaneko M, et al. (1998) Suppression of cells proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-a. Blood 91: 641-648
2. Peschel C, Aulitzky WE, Huber C (1996) Influence of mterferon-α on cytokine expression by the bone marrow microenvironment-impact on treatment of myeloproliferative disorders. Leuk Lymph 22: 129-134
3. Galvani DW (1990) Why does α-interferon work in chronic granulocytic leukaemia? Leuk Lymph 1: 175-178
4. Selleri C, Sato T, Del Vecchio L, et al. (1997) Involvement of Fasmediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia. Blood 89: 957-954
5. Eibl B, Greiter E, Grünewald K, et al. (1995) Expression of c-fos correlates with IFN-α responsiveness in Philadelphia chromosome positive chronic myelogenous leukemia. Cytokin Mol Ther 1: 29-38
6. Hochhaus A, Yan XH, Helmann R, et al. (1997) Expression of interferon regulatory factor (IRF) genes and response to interferon-α in chronic myeloid leukaemia. Leukemia 11: 933-939
7. + T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia. Blood 91: 977-983
8. Conlon K, Urba W, Smith II J, Steis R, et al. (1990) Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65: 2237-2242
9. Wandl U.B, Nagel-Hiemke M, May D, et al. (1992) Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopath 65: 70-74
10. De Mel WCP, Hoffbrand AV, Giles FJ, et al. (1990) Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2',5' oligoadenylate system and clinical response. Br J Haematol 74:452-456
11. Upadhyaya G, Guba SC, Sih SA, et al. (1991) Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 88: 2131-2136
12. Guilhot F, Chastang C, Michallet M, et al (1997) Interferon-a to be combined with cytarabine vs interferon alone in chronic myelogenous leukemia. N Engl J Med 337: 223-229